[1] Frouhari S, Heidari Zh, Tavana Z, Mihanpour H, Sayadi M, Shayan A, et al. [Effect of some hormones related to polycystic ovary syndrome on health-related quality of life]. Iran J Obstet Gynecol Infertil 2016; 18: 17–27. (in Persian).

[2] Trikudanathan S. Polycystic ovarian syndrome. Med Clin North Am 2015; 99: 221–235.

[3] Akbari Nasrekani Z, Fathi M. [Efficacy of 12 weeks aerobic training on body composition, aerobic power and some women-hormones in polycystic ovary syndrome infertile women]. Iran J Obstet Gynecol Infertil 2016; 19: 1–10. (in Persian).

[4] Morris S, Grover S, Sabin MA. What does a diagnostic label of ‘polycystic ovary syndrome’ really mean in adolescence? A review of current practice recommendations. Clin Obes 2016; 6: 1–8.

[5] Hussain A. Polycystic ovary syndrome-diagnosis and treatment. [Master’s Thesis]. Norway: University of Oslo; 2015.

[6] Jonard S, Robert Y, Cortet-Rudelli C, Pigny P, Decanter C, Dewailly D. Ultra-sound examination of polycystic ovaries: Is it worth counting the follicles? Hum Reprod 2003; 18: 598–603.

[7] Farshchian N, Fakheri T, Hezbi A. A comparison of color doppler sonography findings in polycystic ovarian syndrome patients and healthy women. J Babol Univ Med Sci 2015; 17: 61–66.

[8] Deans R. Polycystic ovary syndrome in adolescence. Med Sci 2019; 7: 101.

[9] Deswal R, Narwal V, Dang A, Pundir ChS. The prevalence of polycystic ovary syndrome: A brief systematic review. J Hum Reprod Sci 2020; 13: 261–271.

[10] Sayehmiri F, Kiani F, Sayehmiri K, Maleki F, Ahmadi M, Shohani M. [Prevalence of polycystic ovary syndrome in Iranian women: A systematic review and meta-analysis]. Iran J Obstet Gynecol Infertil 2014; 17: 11–21. (in Persian)

[11] Singh S, Pal N, Shubham S, Sarma DK, Verma V, Marotta F, et al. Polycystic ovary syndrome: Etiology, current management, and future therapeutics. J Clin Med 2023; 12: 1454.

[12] Nandi A, Chen Z, Patel R, Poretsky L. Polycystic ovary syndrome. Endocrinol Metab Clin North Am 2014; 43: 123–147.

[13] Bereda G. Risk factors of atherosclerosis. J Vasc Surg 2022; 10: 1000444.

[14] Fishbein MC, Fishbein GA. Arteriosclerosis: Facts and fancy. Cardiovasc Pathol 2015; 24: 335–342.

[15] Katakami N, Matsuoka T, Shimomura I. Clinical utility of carotid ultrasonography: Application for the management of patients with diabetes. J Diabetes Investig 2019; 10: 883–898.

[16] Buyukkaya R, Besir FH, Yazgan S, Karatas A, Kose SA, Aydin Y, et al. The evaluation of carotid intima-media thickness and visceral obesity as an atherosclerosis predictor in newly-diagnosed polycystic ovary syndrome. Clin Ter 2014; 165: 6–11.

[17] Tripathy P, Sahu A, Sahu M, Nagy A. Ultrasonographic evaluation of intra-abdominal fat distribution and study of its influence on subclinical atherosclerosis in women with polycystic ovarian syndrome. Eur J Obstet Gynecol Reprod Biol 2017; 217: 18–22.

[18] Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41–47.

[19] Allameh Z, Rouholamin S, Adibi A, Mehdipour M, Adeli M. Does carotid intima-media thickness have relationship with polycystic ovary syndrome? Int J Prev Med 2013; 4: 1266–1270.

[20] Jabbour R, Ott J, Eppel W, Frigo P. Carotid intima-media thickness in polycystic ovary syndrome and its association with hormone and lipid profiles. PLoS One 2020; 15: e0232299.

[21] Karoli R, Fatima J, Siddiqi Z, Vatsal P, Sultania AR, Maini S. Study of early atherosclerotic markers in women with polycystic ovary syndrome. Indian J Endocrinol Metab 2012; 16: 1004–1008.

[22] Rahmanpoor H, Ghorbani M, Azarkhish K, Mazloomi S, Kolifarhood G, Forghani F. [Evaluation of carotid atherosclerosis in polycystic ovary syndrome: A case-control study in Zanjan, Iran]. J Zabol Univ Med Sci 2014; 3: 88–96. (in Persian)

[23] Rosenberg SL. The relationship between PCOS and obesity: Which comes first? Sci J Lander College Arts Sci 2019; 13: 34–40.

[24] Pillay P, Carter J, Taylor H, Lewington S, Clarke R. Independent relevance of different measures of adiposity for carotid intima-media thickness in 40 000 adults in UK biobank. J Am Heart Assoc 2023; 12: e026694.

[25] Peppa M, Koliaki C, Nikolopoulos P, Raptis SA. Skeletal muscle insulin resistance in endocrine disease. J Biomed Biotechnol 2010; 2010: 13.

[26] Cesaro A, Michele GD, Fimiani F, Acerbo V, Scherillo G, Signore G, et al. Visceral adipose tissue and residual cardiovascular risk: A pathological link and new therapeutic options. Front Cardiovasc Med 2023; 10: 1187735.

[27] Kim MS, Dao-Tran A, Davidowitz E, Tseng T, Gilsanz V, Ryabets-Lienhard A, et al. Carotid intima-media thickness is associated with increased androgens in adolescents and young adults with classical congenital adrenal hyperplasia. Horm Res Paediatr 2016; 85: 242–249.

[28] Kaur H, Tiwari P, Sharma S, Verma M. An analytical cross-sectional study to assess the effects of smoking on common carotid intima-media thickness and resistivity index among current smokers. J Diagn Med Sonography 2022; 38: 26–34.

[29] Zhang L, Fan F, Qi L, Jia J, Yang Y, Li J, et al. The association between carotid intima-media thickness and new-onset hypertension in a Chinese community-based population. BMC Cardiovasc Disord 2019; 19: 269.